Company Filing History:
Years Active: 1998
Title: Inventor Kenneth Earl Murchison: Innovating Leukocyte Analysis
Introduction
Kenneth Earl Murchison is a distinguished inventor based in Ben Lomond, California. He holds a patent that significantly enhances the analysis of leukocytes within whole blood, addressing a critical need in medical diagnostics. His innovative approach demonstrates both scientific ingenuity and practical application in the field of hematology.
Latest Patents
Murchison's sole patent, titled "Method for preparation and analysis of leukocytes in whole blood," introduces a unique method of flow cytometric analysis of leukocyte subpopulations. This method employs a fluorescence trigger while gating on light scatter versus fluorescence. It proves particularly useful in instances where traditional light scatter parameters fall short, such as analyzing lysed blood samples where removal of lysing agents or unbound labels is not feasible.
Career Highlights
Kenneth Murchison's career is marked by his affiliation with Becton Dickinson and Company, a leading global medical technology firm. His work there emphasizes his commitment to improving laboratory techniques and enhancing the accuracy of blood analysis.
Collaborations
Throughout his career, Murchison has collaborated with notable professionals in the field, including Anne Louise Jackson and Robert A. Hoffman. These collaborations have played a crucial role in advancing the methodologies related to leukocyte analysis and contributing to the broader scientific community.
Conclusion
Kenneth Earl Murchison exemplifies the spirit of innovation in the medical technology sector. His contributions, particularly through his patented method for leukocyte analysis, underline the importance of innovative solutions in health diagnostics. As he continues his work at Becton Dickinson and Company, Murchison's efforts are sure to inspire further advancements and research in the field.